Novartis (NVS) announced on Friday that, following regulatory feedback, it has withdrawn its EU marketing application for Pluvicto, which aimed at broadening the use of the radiotherapy for a specific ...

The long-awaited inevitability is nearly a reality. Both the men's and women's NCAA basketball tournaments are expected to expand to 76 teams, effective next year, sources told CBS Sports on Tuesday.

Aldi is massively expanding its list of banned ingredients in private-label products sold in its stores, the company announced Wednesday. The discount grocery chain already restricts 13 ingredients ...

After announcing in September it was working with industry group DDEX on a standard for disclosing when AI is used in a song, AI credits are launching with DistroKid as the first partner.

If you've even been paying half attention to menswear over the past few years, you'll know that Timothée Chalamet isn't just another well-dressed actor doing the press tour circuit. He's a fashion lad ...

Vertex Pharmaceuticals has shown steady financial growth. Mirum Pharmaceuticals is getting closer to being profitable. Both companies have been expanding through acquisitions. Vertex has built its ...

Arsenal legend Freddie Ljungberg admits defeat to Manchester City is a big psychological blow which will be tough for his former team to recover from. The Gunners suffered a huge setback in the ...

Vertex Pharmaceuticals (NASDAQ: VRTX) and Mirum Pharmaceuticals (NASDAQ: MIRM) are two biotech stocks that share the same blueprint. They are focusing on rare diseases with highly unmet medical needs ...

at the core of their portfolios. That makes sense. After all, blue-chip companies are leaders in their industries. Their names are familiar to investors. Blue-chip stocks are from companies that are ...